@misc{grinshpun2022longitudinal,
  title={Longitudinal circulating tumor DNA (ctDNA) whole-exome sequencing (WES) in the phase Ib/II trial of palbociclib and bazedoxifene reveals genomic dynamics and clonal evolution with the acquisition of treatment resistance in hormone receptor-positive, HER2-negative (HR+ HER2-), advanced breast cancer (ABC).},
  author={Grinshpun, Albert and Tsuji, Junko and Li, Tianyu and Russo, Douglas and Anderson, Leilani and Rees, Rebecca and Cibulskis, Carrie and Leshchiner, Ignaty and Stewart, Chip and Tung, Nadine M and others},
  year={2022},
  publisher={American Society of Clinical Oncology}
}

{"_id":"rPCTcov5RPun3g28K","bibbaseid":"grinshpun-tsuji-li-russo-anderson-rees-cibulskis-leshchiner-etal-longitudinalcirculatingtumordnactdnawholeexomesequencingwesinthephaseibiitrialofpalbociclibandbazedoxifenerevealsgenomicdynamicsandclonalevolutionwiththeacquisitionoftreatmentresistanceinhormonereceptorpositiveher2negativehrher2advancedbreastcancerabc-2022","author_short":["Grinshpun, A.","Tsuji, J.","Li, T.","Russo, D.","Anderson, L.","Rees, R.","Cibulskis, C.","Leshchiner, I.","Stewart, C.","Tung, N. M","others"],"bibdata":{"bibtype":"misc","type":"misc","title":"Longitudinal circulating tumor DNA (ctDNA) whole-exome sequencing (WES) in the phase Ib/II trial of palbociclib and bazedoxifene reveals genomic dynamics and clonal evolution with the acquisition of treatment resistance in hormone receptor-positive, HER2-negative (HR+ HER2-), advanced breast cancer (ABC).","author":[{"propositions":[],"lastnames":["Grinshpun"],"firstnames":["Albert"],"suffixes":[]},{"propositions":[],"lastnames":["Tsuji"],"firstnames":["Junko"],"suffixes":[]},{"propositions":[],"lastnames":["Li"],"firstnames":["Tianyu"],"suffixes":[]},{"propositions":[],"lastnames":["Russo"],"firstnames":["Douglas"],"suffixes":[]},{"propositions":[],"lastnames":["Anderson"],"firstnames":["Leilani"],"suffixes":[]},{"propositions":[],"lastnames":["Rees"],"firstnames":["Rebecca"],"suffixes":[]},{"propositions":[],"lastnames":["Cibulskis"],"firstnames":["Carrie"],"suffixes":[]},{"propositions":[],"lastnames":["Leshchiner"],"firstnames":["Ignaty"],"suffixes":[]},{"propositions":[],"lastnames":["Stewart"],"firstnames":["Chip"],"suffixes":[]},{"propositions":[],"lastnames":["Tung"],"firstnames":["Nadine","M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["others"],"suffixes":[]}],"year":"2022","publisher":"American Society of Clinical Oncology","bibtex":"@misc{grinshpun2022longitudinal,\n title={Longitudinal circulating tumor DNA (ctDNA) whole-exome sequencing (WES) in the phase Ib/II trial of palbociclib and bazedoxifene reveals genomic dynamics and clonal evolution with the acquisition of treatment resistance in hormone receptor-positive, HER2-negative (HR+ HER2-), advanced breast cancer (ABC).},\n author={Grinshpun, Albert and Tsuji, Junko and Li, Tianyu and Russo, Douglas and Anderson, Leilani and Rees, Rebecca and Cibulskis, Carrie and Leshchiner, Ignaty and Stewart, Chip and Tung, Nadine M and others},\n year={2022},\n publisher={American Society of Clinical Oncology}\n}\n\n","author_short":["Grinshpun, A.","Tsuji, J.","Li, T.","Russo, D.","Anderson, L.","Rees, R.","Cibulskis, C.","Leshchiner, I.","Stewart, C.","Tung, N. M","others"],"key":"grinshpun2022longitudinal","id":"grinshpun2022longitudinal","bibbaseid":"grinshpun-tsuji-li-russo-anderson-rees-cibulskis-leshchiner-etal-longitudinalcirculatingtumordnactdnawholeexomesequencingwesinthephaseibiitrialofpalbociclibandbazedoxifenerevealsgenomicdynamicsandclonalevolutionwiththeacquisitionoftreatmentresistanceinhormonereceptorpositiveher2negativehrher2advancedbreastcancerabc-2022","role":"author","urls":{},"metadata":{"authorlinks":{}}},"bibtype":"misc","biburl":"https://bibbase.org/network/files/aX4e85mNvLnP28bmF","dataSources":["hky9vNrwc9uGBMQ9h"],"keywords":[],"search_terms":["longitudinal","circulating","tumor","dna","ctdna","whole","exome","sequencing","wes","phase","trial","palbociclib","bazedoxifene","reveals","genomic","dynamics","clonal","evolution","acquisition","treatment","resistance","hormone","receptor","positive","her2","negative","her2","advanced","breast","cancer","abc","grinshpun","tsuji","li","russo","anderson","rees","cibulskis","leshchiner","stewart","tung","others"],"title":"Longitudinal circulating tumor DNA (ctDNA) whole-exome sequencing (WES) in the phase Ib/II trial of palbociclib and bazedoxifene reveals genomic dynamics and clonal evolution with the acquisition of treatment resistance in hormone receptor-positive, HER2-negative (HR+ HER2-), advanced breast cancer (ABC).","year":2022}